Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study is not being conducted in the United States. The purpose of this study is to
assess the safety and effectiveness of vildagliptin, an unapproved drug, compared to acarbose
in lowering overall blood glucose levels in people with type 2 diabetes who have not been
previously treated with drug therapy to lower their blood sugar.